A dwarf mouse model with decreased GH/IGF-1 activity that does not experience life-span extension: Potential impact of increased adiposity, leptin, and insulin with advancing age

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69 A, Issue 2, 2014, Pages 131-141

  Berryman, Darlene E ^a,b   Lubbers, Ellen R ^b   Magon, Vishakha ^a   List, Edward O ^b   Kopchick, John J ^b  

^a OHIO UNIVERSITY   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

Adipose depots; Aging; Body composition; Growth hormone; Leptin; Obesity; Sex differences

Indexed keywords

ADIPONECTIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN; LEPTIN; SOMATOMEDIN C;

ADIPOSE DEPOTS; AGING; ANIMAL; ARTICLE; BODY COMPOSITION; DISEASE MODEL; DRUG ANTAGONISM; FEMALE; GLUCOSE BLOOD LEVEL; LONGEVITY; MALE; METABOLISM; MOUSE; OBESITY; PHYSIOLOGY; SEX DIFFERENCE; SEX DIFFERENCES; TRANSGENIC MOUSE;

ADIPOSE DEPOTS; AGING; BODY COMPOSITION; GROWTH HORMONE; LEPTIN; OBESITY; SEX DIFFERENCES;

ADIPONECTIN; ADIPOSITY; ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; FEMALE; GROWTH HORMONE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LONGEVITY; MALE; MICE; MICE, TRANSGENIC; RECEPTORS, SOMATOTROPIN; SEX FACTORS;

EID: 84896757194     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt069     Document Type: Article

References (51)

1. Berryman DE, Christiansen JS, Johannsson G, Thorner MO, Kopchick JJ. Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res. 2008;18:455-471.
2. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3:70ra13.
3. Laron Z. Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? Mech Ageing Dev. 2005;126:305-307.
4. Laron Z. The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency. Hormones (Athens). 2008;7:24-27.
5. Berryman DE, List EO, Sackmann-Sala L, Lubbers E, Munn R, Kopchick JJ. Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm IGF Res. 2011;21:113-123.
6. Ding J, Sackmann-Sala L, Kopchick JJ. Mouse models of growth hormone action and aging: a proteomic perspective. Proteomics. 2013;13:674-685.
7. Bartke A. Pleiotropic effects of growth hormone signaling in aging. Trends Endocrinol Metab. 2011;22:437-442.
8. Bartke A. Growth hormone, insulin and aging: the benefts of endocrine defects. Exp Gerontol. 2011;46:108-111.
9. List EO, Sackmann-Sala L, Berryman DE, et al. Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. Endocr Rev. 2011;32:356-386.
10. Brown-Borg HM, Bartke A. GH and IGF1: roles in energy metabolism of long-living GH mutant mice. J Gerontol A Biol Sci Med Sci. 2012;67:652-660.
11. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A. 2001;98:6736-6741.
12. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384:33.
13. Flurkey K, Papaconstantinou J, Harrison DE. The Snell dwarf mutation Pit1 (dw) can increase life span in mice. Mech Ageing Dev. 2002;123:121-130.
14. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology. 2003;144:3799-3810.
15. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK, Kopchick JJ. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res. 2004;14:309-318.
16. Berryman DE, List EO, Palmer AJ, et al. Two-year body composition analyses of long-lived GHR null mice. J Gerontol A Biol Sci Med Sci. 2010;65:31-40.
17. Donahue LR, Beamer WG. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J Endocrinol. 1993;136:91-104.
18. Heiman ML, Tinsley FC, Mattison JA, Hauck S, Bartke A. Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice. Endocrine. 2003;20:149-154.
19. Meyer CW, Korthaus D, Jagla W, et al. A novel missense mutation in the mouse growth hormone gene causes semidominant dwarfsm, hyperghrelinemia, and obesity. Endocrinology. 2004;145:2531-2541.
20. Flint DJ, Binart N, Kopchick J, Kelly P. Effects of growth hormone and prolactin on adipose tissue development and function. Pituitary. 2003;6:97-102.
21. Berryman DE, List EO, Kohn DT, Coschigano KT, Seeley RJ, Kopchick JJ. Effect of growth hormone on susceptibility to dietinduced obesity. Endocrinology. 2006;147:2801-2808.
22. Chen WY, Wight DC, Mehta BV, Wagner TE, Kopchick JJ. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol Endocrinol. 1991;5:1845-1852.
23. Chen WY, White ME, Wagner TE, Kopchick JJ. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology. 1991;129:1402-1408.
24. Chen WY, Wight DC, Chen NY, Coleman TA, Wagner TE, Kopchick JJ. Mutations in the third alpha-helix of bovine growth hormone dramatically affect its distribution in vitro and growth enhancement in transgenic mice. J Biol Chem. 1991;266:2252-2258.
25. Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev. 2002;23:623-646.
26. Yakar S, Setser J, Zhao H, et al. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest. 2004;113:96-105.
27. Knapp JR, Chen WY, Turner ND, Byers FM, Kopchick JJ. Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes. J Anim Sci. 1994;72:2812-2819.
28. Palmer AJ, Chung MY, List EO, et al. Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology. 2009;150:1353-1360.
29. Ebinuma H, Matsuo M. Protease-based ELISA for selective quantification of mouse high-molecular-weight adiponectin. Clin Chim Acta. 2009;401:181-183.
30. Lubbers ER, List EO, Jara A, Sackman-Sala L, Cordoba-Chacon J, Gahete MD, Kineman RD, Boparai R, Bartke A, Kopchick JJ, Berryman DE. Adiponectin in mice with altered GH action: links to insulin sensitivity and longevity? J Endocrinol. 2013;216:363-374.
31. Salmon DM, Flatt JP. Effect of dietary fat content on the incidence of obesity among ad libitum fed mice. Int J Obes. 1985;9:443-449.
32. Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism. 2005;54:281-286.
33. Lim U, Turner SD, Franke AA, et al. Predicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women. PLoS One. 2012;7:e43502.
34. Cicero AF, Magni P, Moré M, et al. Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the brisighella heart study. Int J Endocrinol. 2011;2011:724816.
35. Rollo CD. Growth negatively impacts the life span of mammals. Evol Dev. 2002;4:55-61.
36. Egecioglu E, Bjursell M, Ljungberg A, et al. Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am J Physiol Endocrinol Metab. 2006;290:E317-E325.
37. Meazza C, Vitale G, Pagani S, et al. Common adipokine features of neonates and centenarians. J Pediatr Endocrinol Metab. 2011;24:953-957.
38. Stenholm S, Metter EJ, Roth GS, et al. Relationship between plasma ghrelin, insulin, leptin, interleukin 6, adiponectin, testosterone and longevity in the Baltimore Longitudinal Study of Aging. Aging Clin Exp Res. 2011;23:153-158.
39. Arai Y, Takayama M, Abe Y, Hirose N. Adipokines and aging. J Atheroscler Thromb. 2011;18:545-550.
40. Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to infammation and autoimmunity. Endocr Regul. 2009;43:157-168.
41. La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol. 2004;4:371-379.
42. McKee Alderman J, De Petrillo MA, Gluesenkamp AM, et al. Calorie restriction and dwarf mice in gerontological research. Gerontology. 2010;56:404-409.
43. Kotani K, Sakane N, Saiga K, Kurozawa Y. Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia. 2005;48:2684-2686.
44. Santillán-Benítez JG, Mendieta-Zerón H, Gómez-Oliván LM, Torres-Juárez JJ, González- Bañales JM, Hernández-Peña LV, Ordóñez-Quiroz A. The tetrad BMI, leptin, leptin/adiponectin (L/A) ratio and CA 15-3 are reliable biomarkers of breast cancer. J Clin Lab Anal. 2013;27:12-20.
45. Liao YC, Liang KW, Lee WJ, Lee WL, Lee IT, Wang JS, Ting CT, Sheu WH. Leptin to adiponectin ratio as a useful predictor for cardiac syndrome X. Biomarkers. 2013;18:44-50.
46. Bartke A. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel fndings. Aging Cell. 2008;7:285-290.
47. Khan SM, Hamnvik OP, Brinkoetter M, Mantzoros CS. Leptin as a modulator of neuroendocrine function in humans. Yonsei Med J. 2012;53:671-679.
48. Yasmeen R, Reichert B, Deiuliis J, et al. Autocrine function of aldehyde dehydrogenase 1 as a determinant of diet- and sex-specific differences in visceral adiposity. Diabetes. 2013;62:124-136.
49. Palanivel R, Fullerton MD, Galic S, et al. Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance. Diabetologia. 2012;55:3083-3093.
50. Nikolic DM, Li Y, Liu S, Wang S. Overexpression of constitutively active PKG-I protects female, but not male mice from diet-induced obesity. Obesity (Silver Spring). 2011;19:784-791.
51. Stubbins RE, Holcomb VB, Hong J, Núñez NP. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr. 2012;51:861-870.